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Fasting-induced suppression of the hypothalamic-
pituitary-thyroid (HPT) axis is an adaptive response
to decrease energy expenditure during food depriva-
tion. Previous studies demonstrate that leptin com-
municates nutritional status to the HPT axis through
thyrotropin-releasing hormone (TRH) in the paraven-
tricular nucleus (PVN) of the hypothalamus. Leptin
targets TRH neurons either directly or indirectly via
the arcuate nucleus through pro-opiomelanocortin
(POMC) and agouti-related peptide/neuropeptide Y
(AgRP/NPY) neurons. To evaluate the role of these
pathways in vivo, we developed double knockout
mice that lack both the melanocortin 4 receptor
(MC4R) and NPY. We show that NPY is required for
fasting-induced suppression of Trh expression in
the PVN. However, both MC4R and NPY are required
for activation of hepatic pathways that metabolize T4
during the fasting response. Thus, these signaling
pathways play a key role in the communication of
fasting signals to reduce thyroid hormone levels
both centrally and through a peripheral hepatic
circuit.
INTRODUCTION
Circulating thyroid hormone (TH) levels are critical regulators of
energy expenditure in rodents and man (Barker, 1951; Du Bois,
1936). Thus, their acute regulation in periods of nutritional stress
or illness is an important adaptive mechanism for survival. In hu-
mans, long-term caloric restriction leads to a fall in TH levels,
which is secondary to a fall in leptin levels (Rosenbaum et al.,
2005; Rosenbaum et al., 2002). Similar physiology exists in
rodents during an acute fast where a drop in leptin levels leads
to a fall in both the predominant form of thyroid hormone,
thyroxine (T4), and the active form, triiodothyronine (T3), over
24–48 hr (Ahima et al., 1996; Connors et al., 1985; Le´gra´di
et al., 1997). Additionally, suppression of the hypothalamic-pitu-
itary-thyroid (HPT) axis during nutritional stress extends to both
thyrotropin-releasing hormone (TRH) production in the paraven-780 Cell Metabolism 14, 780–790, December 7, 2011 ª2011 Elseviertricular nucleus (PVN) of the hypothalamus and thyroid-stimu-
lating hormone (TSH) production from the pituitary (Blake et al.,
1991; Blake et al., 1992; Spencer et al., 1983). To further empha-
size the role of leptin in the HPT axis, leptin replacement during
food restriction prevented decreases of TH levels in both hu-
mans and rodents (Ahima et al., 1996; Le´gra´di et al., 1997; Rose-
nbaum et al., 2002). Thus, the nutritional regulation of the HPT
axis by leptin becomes an important paradigm to mechanisti-
cally understand the importance of this axis in regulating energy
expenditure and ultimately body weight.
Two possiblemechanisms have been proposed to explain lep-
tin’sactionson theHPTaxis. These twomechanismsboth involve
hypothalamic neurocircuitry that regulates TRH production in the
PVN: (1) Leptin acts directly through its receptors on hypophysio-
tropic TRH neurons that project to the median eminence to regu-
late TSH production in the pituitary (Harris et al., 2001; Nillni et al.,
2000; Perello et al., 2006); or (2) leptin regulates TRH neurons
indirectly via its actions on pro-opiomelanocortin (POMC) and
agouti-related peptide/neuropeptide Y (AgRP/NPY) neurons in
the arcuate nucleus (Bjørbaek and Hollenberg, 2002; Fekete
et al., 2001; Fekete et al., 2000a; Fekete et al., 2002b; Legradi
et al., 1998). Although these pathways are notmutually exclusive,
genetic data suggest that leptin signaling is absolutely required
for normal function of the HPT axis as mice with leptin receptor
mutations have central hypothyroidism whereas mice that lack
the MC4R or NPY have normal T4 levels at baseline (Bates
et al., 2004; Erickson et al., 1997; Fekete et al., 2004). Contrary
to these observations, the POMC-derived peptide a-melanocyte
stimulating hormone (a-MSH) can stimulate Trh expression in the
PVN, andbothAgRPandNPYcan suppressTrhexpression in the
PVN, suggesting that neurons within the arcuate nucleus could
play a major role in the regulation of the HPT axis through their
action on Trh (Fekete et al., 2001; Fekete et al., 2000a; Fekete
et al., 2002b). Indeed, ablation of the arcuate nucleusbymonoso-
dium L-glutamate in rats prevented a fasting-induced decrease
in Trh mRNA, serum TSH, and T4 levels, strengthening the case
for the role of the arcuate nucleus in metabolic regulation of Trh
(Legradi et al., 1998). However, because MSG may have more
widespread effects, including increased leptin insensitivity, this
experiment did not rule out other pathways for leptin action (Nillni,
2010). Despite these insights, the exact pathway that regulates
leptin’s actions on the HPT axis is not clear.
To definitively identify the pathway that allows for the fasting-
induced fall in TH levels, we developed a genetic approach usingInc.
Figure 1. DKO Mice Have a Similar Meta-
bolic Phenotype as Mc4r–/– Mice
(A) Average body weight of male WT, Npy/,
Mc4r/ and DKO mice from 5–25 weeks of age.
(B) Percent fat mass as measured by DEXA.
(C) CLAMS: Mice were placed in a CLAMS appa-
ratus and monitored for oxygen consumption
(VO2) over a 24 hr period. The dark bars indicate
dark period in the light cycle.
(D) Weekly food intake at 6 and 24 weeks of age.
(A)–(D), data are presented as mean ± SEM, n = 6
per genotype. (A) and (C)–(D) were measured with
repeated-measures two-way ANOVA with Bon-
ferroni post hoc test. (B) was measured with one-
way ANOVA with Tukey’s multiple comparison
post hoc test. a = p < 0.05Mc4r/ versus WT and
Npy/; a’’ = p < 0.001 Mc4r/ versus WT and
Npy/; b = p < 0.05 DKO versus WT and Npy/;
b’ = p < 0.01 DKO versus WT and Npy/; b’’ = p <
0.001 DKO versus WT and Npy/.
(E) ISH was performed on brain sections using
a 35S-labeled riboprobe against mouse TrhmRNA.
Representative images of fed and fasted C57BL/6
mice on chow or HFD are shown of the PVN at
original magnification, 310; scale bar, 50 mm.
Quantification of Trh expression (right panel). Data
are presented as relative pixel densities. Signifi-
cance was tested by two-way ANOVA with Bon-
ferroni post hoc test (n = 4 per diet and fed status).
Data are presented as mean ± SEM. * = p < 0.05.
See also Figures S1 and S2.
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NPY and MC4R Suppress TH Levels during Fastingmice that lacked both MC4R and NPY and thus would be unable
to communicate a-MSH, AgRP, and NPY signals to the PVN.
Importantly, we pair-fed these animals to prevent obesity and
to equalize leptin levels. Remarkably, we show that signaling
through NPY and MC4R controls the fasting-induced suppres-
sion of thyroid hormone levels through two mechanisms: (1)
Fasting-induced suppression of the central axis requires NPY;
and (2) a second pathway based in the liver that enhances the
metabolism of TH requires MC4R and NPY. Thus, MC4R and
NPY signaling engage both central and peripheral targets to
control TH levels during a fast. This engagement of multiple
targets underscores the importance of this pathway in the adap-
tation to nutritional stress.
RESULTS
Obesity Prevents Suppression of the HPT Axis during
Fasting
To develop a genetic approach that would determine the impor-
tance of POMC and AgRP/NPY signaling in the regulation of theCell Metabolism 14, 780–790,HPT axis in vivo we crossed Npy+/ mice
with Mc4r+/ mice to develop WT,
Npy/, Mc4r/, and Mc4r/ Npy/
(DKO) mice (Balthasar et al., 2005; Erick-
son et al., 1996). As shown in Figure 1,
DKO mice display a phenotype similar to
Mc4r/ mice (Figure 1A) with increased
fat mass measured by DEXA (Figure 1B),
decreased energy expenditure measuredvia CLAMS apparatus (Figure 1C), and hyperphagia (Figure 1D)
(Balthasar et al., 2005; Huszar et al., 1997). Like their male coun-
terparts, female DKOmice were similar in phenotype toMc4r/
mice (data not shown). Interestingly, obese DKO mice had
further impaired glucose tolerance compared to Mc4r/ mice
(Figure S1).
Since bothMc4r/ and DKO mice were extremely obese, we
were concerned with their ability to sense a fast and suppress
their HPT axis given their high leptin levels. To test this hypoth-
esis, C57BL/6 mice were placed either on a chow diet or
a high fat diet (HFD) for 14 weeks. As expected, HFD-fed mice
had increased body weight and leptin levels that were 20-fold
higher than WT mice (Figures S2A–S2B). We then subjected
these mice to a 36 hr fast. While leptin levels fell during a fast
in HFD-fed mice, they were over 20 times higher than fasted lep-
tin levels in chow-fed mice (Figure S2B). Whereas total thyroxine
(bound T4 plus free T4 in serum: TT4) and total triiodothyronine
(bound T3 plus free T3 in serum: TT3) levels fell significantly in
chow-fed mice, they did not change in HFD-fed mice as previ-
ously demonstrated in rats (Figures S2C–S2D) (GoodmanDecember 7, 2011 ª2011 Elsevier Inc. 781
Figure 2. Pair-Fed Mice Lacking Both NPY
and MC4R Fail to Suppress Thyroid
Hormone and TSH Levels
(A–C) Average daily food intake (A), Body Weight
(B) and Body Fat percentage (C) of combined
NPY/MC4R cohorts 2 and 3: WT (n = 40), Npy/
(n = 38), pair-fedMc4r/ (Mc4r/PF; n = 20), and
DKO (DKO PF; n = 28), and ad libitum Mc4r/
(Mc4r/ ad lib; n = 11) and DKO (DKO ad lib; n =
12) mice. (A) and (B) were analyzed by repeated-
measures two-way ANOVA with Bonferroni post
hoc test. (C) was analyzed via one-way ANOVA
with Tukey’s multiple comparison post hoc test.
For (A)–(C), data are presented as mean ± SEM.
a’’ = p < 0.001 Mc4r/ ad lib versus WT, Npy/,
Mc4r/ PF, and DKO PF; b’’ = p < 0.001 DKO ad
lib versus WT, Npy/, Mc4r/ PF, and DKO PF;
c = p < 0.05 DKO PF versus WT.
(D) Serum leptin levels were measured in cohort 2
fed and fastedWT (n = 5, n = 7),Npy/ (n = 10, n =
10), Mc4r/ PF (n = 4, n = 4), and DKO PF (n = 6,
n = 5) mice.
(E) Combined cohort 2 and 3 Total T4 (TT4) levels of
fed and fasted WT (n = 23, n = 17), Npy/ (n = 21,
n = 17), Mc4r/ PF (n = 10, n = 10), and DKO PF
(n = 16, n = 12) mice.
(F) Total T3 (TT3) concentration of cohort 2 WT (n =
5, n = 7),Npy/ (n = 10, n = 10),Mc4r/ PF (n = 4,
n = 4), and DKO PF (n = 6, n = 5) mice.
(G) Serum TSH concentration of cohort 2 WT (n =
4, n = 4),Npy/ (n = 10, n = 10),Mc4r/ PF (n = 3,
n = 3), and DKO PF (n = 6, n = 5) mice.
(H) Tshb levels relative to the control gene Ppia
(cyclophilin) were measured via QPCR in cohort 3
WT (n = 18, n = 11), Npy/ (n = 10, n = 8),Mc4r/
PF (n = 7, n = 7), and DKOPF (n = 9, n = 7)mice. For
(D)–(H), data are presented as mean ± SEM.
Significance was measured with two-way ANOVA
with Bonferroni post hoc test. * = p < 0.05; ** = p <
0.01; *** = p < 0.001. See also Figure S3.
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decreased 60% in the PVN of fasted chow-fed animals but did
not fall in the PVN of HFD-fed animals (Figure 1E). Trh mRNA
did not change in the lateral hypothalamic area (LHA), anterior
hypothalamic area (AHA), or the dorsomedial hypothalamus
(DMH) regardless of nutritional status in chow or HFD-fed mice
(Figures S2E–S2J). Taken together these data demonstrate
that obesity prevents fasting-induced suppression of the HPT
axis at 36 hr fasting. Therefore, to properly interpret the roles
of the MC4R and NPY in DKO mice we would need to prevent
obesity in these models.
Pair-Feeding Rescues Obese Phenotype ofMc4r–/–
and DKO Mice
To prevent obesity in Mc4r/ and DKO animals we devel-
oped a pair-feeding paradigm, such that the food intake of
Mc4r/ and DKO mice was adjusted to WT levels on a daily
basis. Importantly, using this method we were able to deliver782 Cell Metabolism 14, 780–790, December 7, 2011 ª2011 Elsevieridentical amounts of food to all genotypes through 9 weeks
of age (Figure 2A), which allowed body weight (Figure 2B)
and fat mass (Figure 2C) to be relatively equalized across
genotypes in the pair-fed groups compared to the ad libi-
tum-fed Mc4r/ and DKO mice. Furthermore, pair-fed
Mc4r/ and DKO mice with a body fat percentage of greater
than 15% as measured by MRI were excluded from the
study.
We next fasted groups of WT, Npy/, and pair-fed Mc4r/
and DKO mice to determine the response of the HPT axis. As
shown in Figure 2D, leptin levels of fed mice were slightly but
not significantly higher in pair-fed Mc4r/ and DKO mice
compared to WT and Npy/ mice but fell equivalently after
the fast. A comparison of the leptin levels of pair-fed Mc4r/
and DKOmice to levels in fed and fasted ad libitum-fedMc4r/
and DKO mice (Figure S3A) confirms the effectiveness of the
pair-feeding paradigm in establishing normal leptin levels in
Mc4r/ and DKO animals.Inc.
Figure 3. NPY Is Required for Fasting-Induced Suppression of Trh
Expression
ISH was performed on brain sections using a 35S-labeled riboprobe against
mouse Trh mRNA. (A) Representative images of fed and fasted WT (n = 5, n =
6), Npy/ (n = 8, n = 9), and pair-fed Mc4r/ PF (n = 4, n = 6) and DKO PF
(n = 4, n = 5) mice are shown of the PVN, 310; scale bar, 50 mm. (B) Quanti-
fication of Trh expression. Data are presented as mean pixel density ± SEM.
Significance was measured with two-way ANOVA with Bonferroni post hoc
test. * = p < 0.05. See also Figure S4.
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Impaired in Npy–/– Mice and Prevented in DKO Mice
To determine the contribution of POMCand AgRP/NPY signaling
in fasting-induced suppression of the HPT axis, we measured
several factors in the HPT axis in fed and fasted WT, Npy/,Cell Mand pair-fed Mc4r/ and DKO mice. Following 36 hr of fasting,
the concentration of TT4 dropped significantly, by 56%, in WT
mice (Figure 2E). As previously described, TT4 fell significantly
by 36% in Npy/ mice, although the drop was not as great as
in WT mice with 36 hr of food deprivation (Erickson et al.,
1997). TT4 concentrations also fell in pair-fed Mc4r
/ mice,
but did not change in pair-fed DKO mice with fasting. As ex-
pected, TT4 concentrations measured in ad libitum-fedMc4r
/
and DKO mice did not change with fasting, consistent with the
impact of very high levels of leptin on the HPT axis (Figure S3B).
Concentrations of TT3 and serum TSH remained unchanged in
fasting pair-fed DKO mice compared to the respective 32%
and 50% drop seen in WT mice (Figures 2F–2G). Whereas TT3
levels fell by 25% in Npy/ mice, serum TSH did not.
Conversely, pair-fed Mc4r/ mice suppressed serum TSH by
31% but not TT3 with fasting. No changes in TT3 or serum TSH
were observed in ad libitum-fedMc4r/ and DKOmice (Figures
S3C–S3D).
Since serum TSH does not always accurately reflect TRH
action, we confirmed the serum TSH data by measuring Tshb
mRNA levels from the pituitaries of a separate cohort of fed
and fasted WT, Npy/, and pair-fed Mc4r/ and DKO mice
via quantitative RT-PCR (QPCR). Fasting Npy/ and pair-fed
DKO mice failed to suppress Tshb compared to WT mice (1.8-
fold) while Tshb expression trended to suppression with fasting
(1.5-fold, p = 0.08) inMc4r/mice (Figure 2H). Thus, at the level
of the pituitary, NPY appears critical for suppression of Tshb and
serum TSH during fasting, which suggests that NPY may
mediate this effect through communication of fasting signals to
TRH neurons in the PVN.
To test this hypothesis, we performed in situ hybridization for
Trh expression in the PVN of the hypothalamus, the location of
hypophysiotropic neurons that project from the PVN to the
median eminence to release TRH peptide. As has been pre-
viously demonstrated, Trh expression was significantly
decreased, by 53%, in fasted WT mice when compared to
fed controls (Figures 3A–3B) (Blake et al., 1991). Similarly,
fasted pair-fed Mc4r/ mice also repressed Trh expression
by 42% in the PVN when compared to fed controls. Impor-
tantly, Trh was only regulated during fasting in WT and Mc4r/
mice in the PVN and not in other areas of the hypothalamus
where Trh is expressed, which includes the AHA, the LHA,
and the DMH (Figures S4A–S4C). Remarkably, fasting did not
regulate Trh levels in the PVN of Npy/ mice. Similar results
were seen in pair-fed DKO mice, validating the key requirement
for NPY in mediating the fasting-induced suppression of Trh
(Figure 3). Furthermore, Trh expression did not change in fast-
ing ad libitum-fed Mc4r/ and DKO mice, again highlighting
the impact of obesity on the HPT axis (Figure S4D). Taken
together, NPY signaling is the major contributor to communi-
cating fasting signals to the central HPT axis, as Trh, Tshb,
and serum TSH remained unchanged in fasted Npy/ and
pair-fed DKO mice. Despite this, TT4 and TT3 levels still drop
in fasted Npy/ mice, but not in pair-fed DKO mice. This
suggests that the MC4R plays a role in suppression of thyroid
hormone levels during fasting through a TRH-independent
pathway. This is further supported by the failure of pair-fed
Mc4r/ mice to fully suppress TT4 levels and TT3 levels during
a fast.etabolism 14, 780–790, December 7, 2011 ª2011 Elsevier Inc. 783
Figure 4. MC4R and NPY Are Necessary for
Upregulation of Nr1i3 and Its Target Genes
during Fasting
Expression of various genes in the liver was
measured via QPCR and normalized to Rn18S
expression in WT (n = 17, n = 10), Npy/ (n = 10,
n = 7), and pair-fed Mc4r/ PF (n = 7, n = 7) and
DKO PF (n = 9, n = 7) mice. (A) Expression of Thrsp
and Fasn. (B) Expression of Nr1i3 and its classical
target gene, Cyp2b10. (C) Expression of the
Nr1i3-target genes involved in hepatic TH metab-
olism: Sult1a1, Sult2a1, Sult1d1, and Ugt1a1. (D)
Expression of Thrb1. In all panels, data are pre-
sented as mean ± SEM. Significance was mea-
sured with two-way ANOVA with Bonferroni post
hoc test. * = p < 0.05; ** = p < 0.01; *** = p < 0.001.
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Requires the MC4R and NPY
To explain the adaptive response of TH levels in Npy/ mice
during a fast despite the absence of Trh repression, we hypothe-
sized that fasting-induced peripheral hepatic metabolism of TH
was operative in Npy/ mice, but not in pair-fed DKO mice (de
Herder et al., 1988). This circuit would allow TH levels to fall, inde-
pendent of TRH, and would require the MC4R. Previous studies
have shown that the orphan nuclear receptor constitutive andros-784 Cell Metabolism 14, 780–790, December 7, 2011 ª2011 Elsevier Inc.tane receptor (CAR), or nuclear receptor
subfamily 1, group I, member 3 (Nr1i3),
and its target genes, sulfotransferases
(Sults) andUDP-glucuronosyltransferases
(Ugts), are pivotal to hepatic TH metabo-
lism as they accelerate deiodination and
clearance of TH (Maglich et al., 2004;
Mol and Visser, 1985; Qatanani et al.,
2005; Vansell and Klaassen, 2002; Visser,
1996). Furthermore, Nr1i3 and several of
its target genes are upregulated in the liver
during fasting to increase TH metabolism
(Maglich et al., 2004). Indeed, fasting-in-
duced repression of TH levels is impaired
in CAR/ mice (Maglich et al., 2004).
First, to establish the sensitivity of the
livers of Npy/ and pair-fed Mc4r/
and DKO mice to fasting signals, we
measured expression of lipogenic genes
that decrease during fasting via QPCR
(Carr et al., 1984; Clarke et al., 1990).
Thyroid hormone responsive SPOT14
(Thrsp) mRNAwas significantly repressed
with fasting in all genotypes (Figure 4A)
while fatty acid synthase (Fasn) mRNA
levels also decreased with fasting in WT
(2.6-fold) and Npy/ (3.9-fold) mice and
trended toward reduced levels in pair-
fed Mc4r/ (2.1-fold, p = 0.055) and
DKO (2.6-fold, p = 0.051) mice.
We next assessed the roles of MC4R
and NPY signaling pathways in the regu-
lation of Nr1i3 and its target genes in theliver. Nr1i3 expression was upregulated during fasting (1.8-
fold, Figure 4B) inWTmice, which has been demonstrated previ-
ously (Maglich et al., 2004). Additionally, Nr1i3 expression
increased with fasting in Npy/ mice (2.1-fold), however
expression of Nr1i3 remained unchanged in pair-fed Mc4r/
and DKO mice. To understand the impact of impaired Nr1i3
regulation during fasting, we measured the expression of
the classic Nr1i3-target gene, cytochrome p450, family 2, sub-
family b, polypeptide 10 (Cyp2b10) (Honkakoski et al., 1998).
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and our results agree, as WT (8.4-fold) and Npy/ (18.8-fold)
mice both upregulate hepatic Cyp2b10 expression following
a 36 hr fast (Figure 4B) (Brown et al., 1995). Cyp2b10 expression
in pair-fed DKO mice showed no response to fasting, whereas
pair-fed Mc4r/ mice trended toward an upregulation (5.7-
fold, p = 0.062). These results implicate both MC4R and NPY
in Nr1i3-mediated regulation of hepatic TH metabolism, as
Cyp2b10 may respond to fasting in pair-fed Mc4r/ mice, but
not in DKO mice.
As failure of hepatic Nr1i3 to respond to fasting signals in
Mc4r/ and DKO mice may explain the inability of DKO mice
to suppress TH levels during a fast, we next measured the
Nr1i3 targets responsible for hepatic thyroid hormone metabo-
lism. Previous studies have demonstrated that Phase II sulfo-
transferases mediate hepatic metabolism of TH by sulfating
the phenol group and marking TH for inactivation, which occurs
via the type 1 deiodinase (Mol and Visser, 1985). Sulfotransfer-
ase 1A1 (Sult1a1), which sulfates TH in vitro and has a high
affinity for T4 and T3, is upregulated during fasting (Kester
et al., 1999; Li et al., 2001; Maglich et al., 2004). Sult1a1 expres-
sion was significantly increased with fasting in WT (2.3-fold) and
Npy/ (2.5-fold) mice compared to their fed counterparts (Fig-
ure 4C). Both pair-fed Mc4r/ and DKO mice failed to upregu-
late Sult1a1 with fasting. Additionally, we examined two other
sulfotransferases: Sult2a1 preferentially sulfates T3, and Sult1d1
has a very similar protein structure to Sult1a1, although its role in
the liver is still unknown (Li and Anderson, 1999; Sakakibara
et al., 1995). Both genes were significantly upregulated in WT
(5.1-fold and 2.5-fold, respectively), Npy/ (3.7-fold and 3.6-
fold, respectively) and pair-fed Mc4r/ (3.9-fold and 2.1-fold,
respectively) mice, whereas pair-fed DKO mice did not regulate
these genes during fasting (Figure 4C). Taken together, these
data confirm that pair-fed DKO mice have impaired Nr1i3-medi-
ated hepatic TH metabolism. To a lesser degree, pair-fed
Mc4r/ mice are also defective in Nr1i3 signaling, as they fail
to upregulate both Nr1i3 and Sult1a1 with fasting, but
Cyp2b10, Sult2A1, and Sult1d1 are responsive. Removal of
NPY signaling in addition to MC4R signaling ablates the liver’s
ability to metabolize TH via sulfation.
Nr1i3 also regulates another pathway of phase II TH metabo-
lism, glucuronidation. Conjugation of TH by Ugts increases the
water solubility of TH, promoting biliary excretion (Burchell and
Coughtrie, 1989). We measured the expression of the phenol/
bilirubin UGT 1 family, polypeptide A1 (Ugt1a1) responsible for
the glucuronidation of T4 (Beetstra et al., 1991; Findlay et al.,
2000). Following a 36 hr fast, Ugt1a1 expression was upregu-
lated in both WT (3.8-fold) and Npy/ (3.5-fold) mouse livers
compared to fed counterparts (Figure 4C) (Maglich et al.,
2004). No change in Ugt1a1 expression was detected in pair-
fed Mc4r/ and DKO mice. These data further emphasize the
role of MC4R and NPY in Nr1i3-mediated hepatic metabolism
as both sulfation and glucuronidation of TH are impaired in
pair-fed DKO mice. Furthermore, these results underline the
mechanism by which Npy/ mice and not DKO mice are able
to repress TH levels during fasting despite impaired central
HPT axis regulation. To ensure TH signaling was not impacted
in fasting mouse livers, we measured the expression of thyroid
hormone receptor b1 (Thrb1) mRNA levels. Thrb1 levels wereCell Mnot affected by fasting or by deletion of NPY, MC4R, or both
(Figure 4D).
Taken together, these data demonstrate that signaling through
NPY and the central melanocortin system regulates peripheral
thyroid hormone metabolism in the liver and provides evidence
of an additional role for this pathway in the regulation of energy
expenditure.
Sulfotransferases Become Nr1i3-Resistant with HFD
To determine the impact of obesity and high leptin levels on
thyroid hormone metabolism in the liver, we examined the
expression of Nr1i3 mRNA and its target genes in the livers of
mice on a chow diet or HFD. As before, we first measured Thrsp
and Fasn expression to determine the sensitivity of livers to fast-
ing in mice on a HFD. Both Thrsp and Fasn expression
decreased with fasting in mice on a chow diet (3.8-fold and
1.4-fold, respectively) and HFD (3.6-fold and 2.7-fold, respec-
tively, Figure 5A). Next, we measured Nr1i3 expression during
fasting in HFD-fed mice. Nr1i3 levels were upregulated during
fasting in mice on a HFD (3.9-fold) compared to their fed
controls, which was similar to mice on a chow diet (3.2-fold, Fig-
ure 5B). The classic Nr1i3 target, Cyp2b10, was increased in
response to fasting in mice on a chow diet (6.0-fold, Figure 5B).
However, there was no change in Cyp2b10 levels in fasted mice
on a HFD. Additionally, HFD-fed mice failed to upregulate the
expression of Sult1a1, Sult2a1, and Sult1d1 during fasting,
whereas Ugt1a1 levels increased with fasting (2.3-fold, Fig-
ure 5C). Thrb1 levels were unaffected by HFD (Figure 5D).
Although Nr1i3 expression is responsive to fasting in mice on
HFD, these data suggest that the expression of Cyp2b10 and
sulfotransferases are resistant to Nr1i3-mediated induction
during fasting. Resistance to Nr1i3 on a HFD does not permeate
to all target genes since Ugt1a1 still increases during fasting in
HFD-fed mice.
DISCUSSION
Nutritional regulation of theHPTaxis providesan important adap-
tive response to caloric restriction. Indeed, humanswho undergo
weight loss or controlled caloric restriction experience both
reduced TSH and thyroid hormone levels (Rosenbaum et al.,
2005; Rosenbaum et al., 2002). Previous studies in both humans
and rodents have demonstrated that the fall in leptin levels during
caloric restriction controls thyroid hormone levels (Ahima et al.,
1996; Rosenbaum et al., 2002; Sanchez et al., 2004). Prevailing
hypotheses suggest that leptin’s role, which can be either direct
through leptin receptors in the PVN or indirect via POMC and
AgRP/NPY neurons in the arcuate nucleus, is mediated by its
ability to regulate Trh expression in hypophysiotropic neurons
in the PVN (Fekete et al., 2001; Fekete et al., 2000a; Fekete
et al., 2002b; Huo et al., 2004; Kim et al., 2000; Le´gra´di et al.,
1997; Legradi et al., 1998). While showing the importance of
POMC and AgRP/NPY signaling in the regulation of Trh expres-
sion, we also demonstrate their effect on a key peripheral hepatic
circuit that controls thyroid hormone levels in the setting of
nutritional stress. Thus, leptin engages the HPT axis on multiple
levels to control energy expenditure during nutritional stress.
Prior to this report, the specific roles of arcuate nucleus neuro-
peptides downstream of leptin in the regulation of Trh geneetabolism 14, 780–790, December 7, 2011 ª2011 Elsevier Inc. 785
Figure 5. Genes Enhancing Hepatic Thyroid Hormone Metabolism
are Nr1i3-Resistant in HFD-Fed Mice
Expression of various genes in the liver was measured via QPCR and
normalized to Rn18S expression in fed and fasted C57BL/6 mice on chow
(n = 4, n = 4) or HFD (n = 4, n = 4). (A) Expression of Thrsp and Fasn. (B)
Expression of Nr1i3 and Cyp2b10. (C) Expression of the Nr1i3-target
genes: Sult1a1, Sult2a1, Sult1d1, and Ugt1a1. (D) Expression of Thrb1. In all
panels, data are presented as mean ± SEM. Significance was measured
with two-way ANOVA with Bonferroni post hoc test. * = p < 0.05; ** = p < 0.01;
*** = p < 0.001.
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created mice that lack either MC4R signaling or NPY signaling or
both. Although we have deleted MC4R and NPY signaling glob-
ally, reports to date implicate the arcuate nucleus as the source786 Cell Metabolism 14, 780–790, December 7, 2011 ª2011 Elsevierof NPY, AgRP, and a-MSH to the PVN (Fekete et al., 2001; Fe-
kete et al., 2000a; Legradi et al., 1998). Previous studies that
modified NPY signaling in different areas of the hypothalamus
did not report abnormalities in thyroid hormone levels (Chao
et al., 2011; Gardiner et al., 2005; Tiesjema et al., 2007; Tiesjema
et al., 2009; Yang et al., 2009). Importantly, we had to control for
the obese phenotype in Mc4r/ and DKO mice in order to use
thesemodels as the high leptin levels present in obesity preclude
a fall in thyroid hormone levels during a fast. As suggested from
earlier studies, input from the arcuate nucleus is not required for
basal function of the HPT axis, as Mc4r/, Npy/, and DKO
mice all have normal TH, serum TSH, and Tshb levels at baseline
(Erickson et al., 1997; Fekete et al., 2004). In contrast, mice with
leptin receptor mutations that impair signal transducer and acti-
vator of transcription 3 (STAT3) signaling have central hypothy-
roidism (Bates et al., 2004). Taken together, these contrasting
data suggest that leptin acts independently of a-MSH, AgRP,
and NPY to establish the set point of the HPT axis in the basal
fed state (Perello et al., 2010). Although this does suggest a direct
action of leptin on TRH neurons, it remains possible that cocaine
and amphetamine-regulated transcript (CART) production in the
arcuate nucleus could play a role initiating the set point of the
HPT axis (Broberger, 1999; Fekete et al., 2000b; Ka´da´r et al.,
2010; Raptis et al., 2004).
Unlike the basal state, the indirect pathway plays a critical role
in fasting. The data presented herein demonstrate that NPY
signaling is required for suppression of Trh in hypophysiotropic
TRH neurons and that both the MC4R and NPY signaling path-
ways are required for the full suppression in TH levels seen
during a fast (Figure 6). It is likely that NPY targets TRH neurons
via the NPY Y1 or Y5 receptors and represses Trh expression by
downregulation of the cAMP-PKA pathway, a known activator of
Trh expression (Fekete et al., 2002a; Herzog et al., 1992; Sarkar
and Lechan, 2003). The failure of Npy/ mice to repress Tshb
during a fast suggests that TRH peptide levels in these animals
are also unchanged and further establishes the role of NPY in
controlling Trh expression in the PVN.
Despite the clear role of NPY in controlling fasting-induced
suppression of Trh expression, TT4 and TT3 levels were still
partially decreased in Npy/mice during a fast, which indicates
that another pathway controlling TH levels must be operative.
Strikingly, the HPT axis was entirely resistant to fasting in pair-
fed DKO animals, demonstrating that the separate pathway
controlling TH levels may require the MC4R. While it is possible
that changes in TSH bioactivity contribute to the fasting
response of the HPT axis in general, this is unlikely in DKO
mice. Here, serum TSH and TT4 levels are the same between
fed and fasted mice, which is indicative of similar TSH bioactivity
(Nikrodhanond et al., 2006). Likewise, serum TSH and TT4 levels
are similar across all genotypes in the fed state, suggesting that
TSH bioactivity is not altered by MC4R and/or NPY deletion.
Certainly, when Trh falls during a fast inWT and pair-fedMc4r/
mice, both total and biologically active serum TSH may fall.
Given that theMC4R activates key hepatic pathways that control
metabolism, we focused on the hepatic metabolism of TH due to
its important role in determining TH levels during acute illness
(Nogueiras et al., 2007; Wiersinga, 2005). Notably, we have
demonstrated that the MC4R and NPY are required for the fast-
ing-induced upregulation of the nuclear receptor Nr1i3, whichInc.
Figure 6. Model of NPY and MC4R Signaling in
T4 Regulation during Fasting
(A) During fasting, reduced leptin levels invoke an increase
in Npy expression in the arcuate nucleus. NPY signals
through Y1 and Y5 receptors in the PVN to repress Trh
expression. Central repression of Trh leads to a decrease
in TshbmRNA levels in the pituitary and, thus, reduced T4
and T3 levels from the thyroid. Trh and serum TSH levels
remain unchanged in fasting Npy/ mice, yet T4 and T3
levels are decreased. Adapted from Vella and Hollenberg
(2009) with permission of The Endocrine Society.
(B) Npy/ mice are able to suppress TH levels during
fasting throughNr1i3-mediated hepaticmetabolism of TH,
which requires both MC4R and NPY. The MC4R and NPY
may act on the liver directly, through sympathetic outputs
or a combination of both. The Nr1i3-targets SULT1A1,
SULT2A1, SULT1D1, and UGT1A1 inactivate TH through
sulfation (T4S) or glucuronidation (T4G). These genes are
regulated during fasting in Npy/ mice, but not in DKO
mice. T4S is converted to reverse T3 sulfate (rT3S) by the
type 1 deiodinase (Dio1), and T4G is cleared through biliary
excretion. 3V = third ventricle. AgRP = agouti-related
peptide. a-MSH = a-melanocyte-stimulating hormone.
Nr1i3 = constitutive androstane receptor. CNS = central
nervous system. Dio1 = type 1 deiodinase. MC4R = mel-
anocortin 4 receptor. Ob-Rb = leptin receptor, long form.
NPY = neuropeptide Y. POMC = pro-opiomelanocortin.
PVN = paraventricular nucleus. Sults = sulfotransferases.
T3 = triiodothyronine. rT3S = reverse triiodothyronine
sulfate. T4 = thyroxine. T4G = glucuronidated thyroxine.
T4S = thyroxine sulfate. TSH = thyroid-stimulating
hormone. Trh = thyrotropin-releasing hormone. Ugt1a1 =
UDP-glucuronosyltransferase 1A1. Y1, Y5 = NPY
receptors.
Cell Metabolism
NPY and MC4R Suppress TH Levels during Fastingthen controls the expression of key sulfotransferases and
Ugt1A1 that are necessary for the metabolism and excretion of
T4 and T3 (Maglich et al., 2004). Whereas pair-fed Mc4r
/
mice are partially deficient in the activation of this Nr1i3-medi-
ated pathway, DKO mice are completely defective, further sup-
porting the concept of a compound effect by NPY and MC4R
signaling on TH levels (Lechan and Fekete, 2006). Further work
will be required to delineate how the hypothalamic neurocircui-
try, sympathetic output, and/or direct effects controlled by
MC4R and NPY signaling regulate Nr1i3-driven metabolism of
TH in the liver. Importantly, we have seen upregulation of Nr1i3
and its targets at least as early as 16 hr of fasting (data not
shown), consistent with both the measured 13–18 hr half-life of
T4 in mice and the greater than 50% drop in TT4 levels during
a 36 hr fast, which supports the relevance of this pathway in vivo
(van Buul-Offers et al., 1983).
In summary, the development of mice that lack key arcuate
nucleus inputs to hypophysiotropic TRH neurons in the PVN
has allowed us to establish the mechanism by which leptin regu-
lates the HPT axis during fasting. While we demonstrate the
unique requirement of NPY signaling for suppression of the
central axis, we identify a fasting-induced hepatic pathway
necessary for full suppression of TH levels that requires both
MC4R and NPY signaling and is independent of TRH expression
(Figure 6). These data suggest that the fall in TH levels seen
during caloric restriction in humans could be targeted either cen-
trally or peripherally and that the fasting-induced activation of theCell MMC4R and NPY controls not only food intake but also energy
expenditure through the regulation of TH levels.EXPERIMENTAL PROCEDURES
Animals
All experiments were approved by the Beth Israel Deaconess Medical Center
Institutional Animal Care and Use Committee. For HFD experiments, male
C57BL/6 mice were obtained from The Jackson Laboratory (Bar Harbor,
ME). NPY/MC4R mice were generated by crossing the previously described
mice heterozygous for the loxTB Mc4r allele (Mc4r+/) with mice heterozy-
gous for a functional Npy allele (Npy+/) (Balthasar et al., 2005; Erickson
et al., 1996). Details of the cohorts in these studies are provided in the Supple-
mental Experimental Procedures. Collections of serum, flash frozen tissue,
and formalin-fixed brains and storage have been previously described (Asta-
pova et al., 2011; Sugrue et al., 2010). All mice were given free access to
water and the appropriate diet. In fasting experiments, mice were fasted for
36 hr. In pair-feeding experiments, obesity-prone Mc4r/ and DKO mice
were fed the same amount of food consumed by WT mice on the previous
day, from weaning to the end of the experiment. Pair-fed Mc4r/ and DKO
mice with a body fat percentage of greater than 15% were excluded from
the study.
CLAMS
NPY/MC4R mice from cohort 1 were placed in a Comprehensive Lab Animal
Monitoring System apparatus (Columbus Instruments, Columbus OH) at
8–12 weeks of age and monitored for oxygen consumption, using a previously
described protocol (Segal-Lieberman et al., 2003a; Segal-Lieberman et al.,
2003b). Mice were acclimated in CLAMS cages for 48 hr prior to measurement
of metabolic parameters.etabolism 14, 780–790, December 7, 2011 ª2011 Elsevier Inc. 787
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Body mass composition of male and female mice from NPY/MC4R cohort 1
was measured at 18–20 weeks of age by dual energy X-ray absorptiometry
using a densitometer for mice (Piximus Lunar PIXI 51048).
EchoMRI
At 9 weeks of age, NPY/MC4R mice from cohorts 2 and 3 were subjected to
magnetic resonance imaging (MRI) using EchoMRI (Echo Medical Systems,
Houston, TX) to determine the body composition.
Serum Analysis
Total serum T4 (TT4) and T3 (TT3) were measured by solid-phase RIA (Coat-a-
Count; Diagnostic Products Corp., Los Angeles, CA) in 25 and 50 ml of serum,
respectively. Serum leptin concentration was measured via ELISA (Quantikine
MMouse Leptin Immunoassay, R & D Systems, Minneapolis, MN). Serum TSH
was measured via IRMA (TSH IRMA, ALPCO, Salem, NH) in 100 ml of serum.
Real-Time Quantitative PCR
Total RNA was extracted from frozen tissues with STAT-60 reagent (Tel-Test,
Friendswood, TX). Then 0.5 mg of total RNA was reverse transcribed using
Advantage RT-for-PCR kit (CLONTECH,Mountain View, CA) with random hex-
amer primers. TaqMan gene expression assays for all mRNAswere purchased
from Applied Biosystems (Carlsbad, CA). Quantitative PCR was performed in
triplicate using the 800HT thermal cycler (Applied Biosystems, Foster City,
CA). Relative mRNA levels were calculated using the standard curve method
and normalized to peptidylprolyl isomerase A (cyclophilin, Ppia) (pituitary) or
18S ribosomal RNA (Rn18S, liver).
In Situ Hybridization
Trh expression was detected by ISH using 35S-radiolabeled antisense ribop-
robe on formalin-fixed brain slices as described previously (Sugrue et al.,
2010). Dark-field digital images of the paraventricular nucleus (PVN), the ante-
rior hypothalamic area (AHA), dorsomedial hypothalamus (DMH), and lateral
hypothalamic area (LHA) were acquired with the same exposure time, bright-
ness, and contrast on Zeiss Axioimager Z1 with Axiovision 4.5 software
(Oberkochen, Germany). The 103magnification images were quantified using
ImageJ (Sugrue et al., 2010). To ensure that hypophysiotropic neurons in the
PVN were the focus of Trh mRNA measurements, quantification of brain
sections was limited to the medial portion of the PVN, which has been
described in detail recently (Ka´da´r et al., 2010). Positive pixels per unit area
(pixel density) was calculated on both sides of the PVN by highlighting the
medial portion of the PVN excluding the periventricular zone and subtracting
background from areas not expressing Trh. Pixel density per mouse was aver-
aged from a minimum of three sections of the medial portion of the PVN.
Statistical Analyses
Data are presented as samplemeans±SEM.Sample numbers range fromn=3
to n = 40 and are stated specifically within the text or figure legends. The text or
figure legends highlight how differences between groups were measured,
which includes unpaired t test, one-way ANOVA with Tukey’s multiple com-
parison post hoc test, repeated-measures two-way ANOVA with Bonferroni
post hoc test, and two-way ANOVA with Bonferroni post hoc test.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures, Supplemental Experimental
Procedures, and Supplemental References and can be found with this article
online at doi:10.1016/j.cmet.2011.10.009.
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